Salazopyrin-induced fulminant hepatitis in two children treated for Crohn's disease.

Citation
M. Besnard et al., Salazopyrin-induced fulminant hepatitis in two children treated for Crohn's disease., ARCH PED, 6(6), 1999, pp. 643-646
Citations number
13
Categorie Soggetti
Pediatrics
Journal title
ARCHIVES DE PEDIATRIE
ISSN journal
0929693X → ACNP
Volume
6
Issue
6
Year of publication
1999
Pages
643 - 646
Database
ISI
SICI code
0929-693X(199906)6:6<643:SFHITC>2.0.ZU;2-J
Abstract
The main adverse effects of salazopyrin are usually dose-dependant and mild . Exceptionally, idiosyncratic reactions occur which may be life-threatenin g. Case reports. - Two 10-year old children were treated for Crohn's disease w ith salazopyrin. At day 21 and day 10 respectively, pharyngitis, rash, and fever were noted. During the following days, high-grade fever persisted, wh ile jaundice, severe cytolysis and acute liver failure also occurred. Drug hepatoxicity was suspected and salazopyrin was withdrawn on day 29 and day 24 respectively. Development of hepatic encephalopathy led to urgent liver transplantation in both cases. Conclusion. - Salazopyrin is a possible cause of fulminant immunoallergic h epatis. Prompt therapeutic interruption is urgent, but it may not alter the outcome and or preclude the need for liver transplantation. We suggest tha t salazopyrin therapy be avoided in pediatric inflammatory bowel disease wh enever possible, and that the use of pure amino- salicylates be preferred. (C) 1999 Elsevier, Paris.